Antibiotic Treatment Duration for Bacterial Infections - A Systematic Review and Critical Appraisal
Mo, Y.; Tan, W. C.; Cooper, B. S.
Show abstract
Reducing antibiotic treatment duration is a key stewardship intervention to mitigate antimicrobial resistance (AMR). We performed a systematic review of antibiotic duration randomised controlled trials for treatment or prevention of bacterial infections in humans, appraised their methodologies and identified gaps in evidence. All randomised trials indexed in MEDLINE and EMBASE up to October 2022 which compared different treatment durations were included. We found 296 trials, of which 85% showed equivalence or non-inferiority. The majority (73%) considered treatment for respiratory tract infections, genitourinary infections, and post-surgical prophylaxis. Few trials studied severe infections, such as bloodstream infections and ventilator-associated pneumonia. Trial designs shifted from superiority (74%, 178/242 before 2016) to non-inferiority (74%, 40/54 after 2016). 94% of the trials that defined a per- protocol population reported non-adherence, which may increase the probability of concluding non-inferiority. Only 9 trials collected data to demonstrate the effect of antibiotic duration on AMR colonisation. RegistrationPROSPERO 2021 CRD42021276209 FundingNational Research Foundation Singapore Central Gap Fund; National Medical Research Council, Singapore; Medical Research Council, UK
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Criteria to Achieve Safe Antimicrobial Intravenous-to-Oral Switch in Hospitalised Adult Populations: A Systematic Rapid Review 96%
- Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis 96%
- Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: systematic review and meta-analysis 94%
Similar papers in this journal
- Antibiotics and hospital-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update 96%
- Estimating the cost of antibiotic use on future collateral resistance: a retrospective comparison of cefuroxime versus cefazolin and amoxicillin/clavulanate 92%
- Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records 92%
Similar papers in this journal
- Prevalence of Bacterial Coinfection and Patterns of Antibiotics Prescribing in Patients with COVID-19: A Systematic review and Meta-Analysis 95%
- Antimicrobial agents for the treatment of enteric fever chronic carriage: A systematic review 94%
- Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU) 94%
Similar papers in this journal
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 92%
- Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anaemic elective surgery patients: a systematic review 92%
- Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 91%
Similar papers in this journal
- Serum Concentration of Continuously administered Vancomycin influences Efficacy and Safety in Critically Ill Adults: A Systematic Review 94%
- Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial 91%
- Attitudes to phage therapy among Australian infectious diseases physicians 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.